Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model

被引:6
作者
Bedenic, Branka
Topic, Marijana
Budimir, Ana
Bubonja, Marina
机构
[1] Univ Zagreb, Sch Med, Dept Microbiol, HR-10000 Zagreb, Croatia
[2] Clin Hosp Ctr, Dept Clin & Mol Microbiol, Zagreb, Croatia
[3] Med Sch Rijeka, Dept Microbiol, Rijeka, Croatia
关键词
bactericidal activity; urinary; beta-lactam antibiotics; fluoroquinolones; linezolid;
D O I
10.1159/000095969
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: In this investigation, the urine samples obtained in a single oral-dose pharmacokinetic study were examined for their bactericidal activity against a range of relevant urinary tract pathogens. Methods:Six healthy volunteers received a single oral dose of ten oral antibiotics available in Croatia. Urine samples were taken every 2 h during the whole dosing interval of the particular antibiotic. The urinary bactericidal activity was tested by determination of urinary bactericidal titers. Results: All antibiotics showed a significant urinary bactericidal activity against non-extended spectrum beta-lactamase Escherichia coli and Proteus mirabilis. Fluoroquinolones displayed high and persisting levels of urinary bactericidal activity against all gram-negative bacteria and Staphylococcus saprophyticus. Conclusions: Average urinary bactericidal activity can be predicted from in vitro susceptibility testing, but we expect that there will be patients with a low level of urinary bactericidal activity. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:293 / 297
页数:5
相关论文
共 10 条
  • [1] Bergan, 1997, URINARY TRACT INFECT, V1, P74
  • [2] The influence of urine on the in vitro antimicrobial activity of various antibiotics against different Escherichia coli phenotypes
    Büyükbaba-Boral, Ö
    Gönüllü, N
    Küçükbasmaci, Ö
    Ang-Küçüker, M
    Ang, Ö
    [J]. CHEMOTHERAPY, 2004, 50 (01) : 35 - 39
  • [3] JOHNSON JR, 1998, URINARY TRACT INFECT, P251
  • [4] Urinary excretion and bactericidal activities of gemifloxacin and ofloxacin after a single oral dose in healthy volunteers
    Naber, CK
    Hammer, M
    Kinzig-Schippers, M
    Sauber, C
    Sörgel, F
    Bygate, EA
    Fairless, AJ
    Machka, K
    Naber, KG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) : 3524 - 3530
  • [5] National Committee for Clinical Laboratory Standards, 1993, M2A5 NCCLS
  • [6] *NCCLS, 2000, M7A5 NCCLS, P1
  • [7] Urinary tract infection in adults: research priorities and strategies
    Ronald, AR
    Nicolle, LE
    Stamm, E
    Krieger, J
    Warren, J
    Schaeffer, A
    Naber, KG
    Hooton, TM
    Johnson, J
    Chambers, S
    Andriole, V
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (04) : 343 - 348
  • [8] Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose
    Wagenlehner, FME
    Wydra, S
    Onda, H
    Kinzig-Schippers, M
    Sörgel, F
    Naber, KG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) : 3789 - 3794
  • [9] Wise Richard, 1998, Clin Microbiol Infect, V4, P392, DOI 10.1111/j.1469-0691.1998.tb00083.x
  • [10] INFLUENCE OF HUMAN URINE ON THE INVITRO ACTIVITY AND POSTANTIBIOTIC EFFECT OF CIPROFLOXACIN AGAINST ESCHERICHIA-COLI
    ZHANEL, GG
    KARLOWSKY, JA
    DAVIDSON, RJ
    HOBAN, DJ
    [J]. CHEMOTHERAPY, 1991, 37 (03) : 218 - 223